期刊
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE
卷 3, 期 4, 页码 583-597出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsptsci.0c00023
关键词
trefoil factor family; TFF1; TFF2; TFF3; mucosal protection; gastrointestinal disorders; epithelial wound healing; peptide drug development
资金
- European Research Council under the European Union's Horizon 2020 research and innovation program [714366]
- Australian Research Council (ARC) [DE150100784, DP190101667]
- NHMRC Australia [1139366, 1140297, 1156427]
- ARC [DP180101395]
- University of Queensland International Postgraduate Scholarship
- National Health and Medical Research Council of Australia [1156427] Funding Source: NHMRC
Trefoil factor family peptides (TFF1, TFF2, and TFF3) are key players in protecting, maintaining, and repairing the gastrointestinal tract. Accordingly, they have the therapeutic potential to treat and prevent a variety of gastrointestinal disorders associated with mucosal damage. TFF peptides share a conserved motif, including three disulfide bonds that stabilize a well-defined three-loop-structure reminiscent of a trefoil. Although multiple functions have been described for TFF peptides, their mechanisms at the molecular level remain poorly understood. This review presents the status quo of TFF research relating to gastrointestinal disorders. Putative TFF receptors and protein partners are described and critically evaluated. The therapeutic potential of these peptides in gastrointestinal disorders where altered mucosal biology plays a crucial role in the underlying etiology is discussed. Finally, areas of investigation that require further research are addressed. Thus, this review provides a comprehensive update on TFF literature as well as guidance toward future research to better understand this peptide family and its therapeutic potential for the treatment of gastrointestinal disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据